These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 6248718

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prospective study of the prevalence and symptomatology of cytomegalovirus infection in renal transplant recipients.
    Chatterjee SN, Jordan GW.
    Transplantation; 1979 Dec; 28(6):457-60. PubMed ID: 229594
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The impact of pretransplant cytomegalovirus infection on acute renal allograft rejection.
    Chen JH, Mao YY, He Q, Wu JY, Lv R.
    Transplant Proc; 2005 Dec; 37(10):4203-7. PubMed ID: 16387078
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection.
    Reischig T, Jindra P, Svecová M, Kormunda S, Opatrný K, Treska V.
    J Clin Virol; 2006 Jun; 36(2):146-51. PubMed ID: 16531113
    [Abstract] [Full Text] [Related]

  • 9. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
    Aranda-Verástegui F, Alberú J, Soto-Ramírez LE, González-Aguirre H, Muñoz Trejo T, Mancilla E, Díliz H, Correa-Rotter R, Sierra-Madero J.
    Rev Invest Clin; 2002 Jun; 54(3):198-203. PubMed ID: 12183888
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Is screening for IgG antibody to cytomegalovirus and Epstein-Barr virus infections mandatory in potential renal transplant recipients and donors in Iran?
    Saghafi H, Qorashi M, Heidari A.
    Transplant Proc; 2009 Sep; 41(7):2761-3. PubMed ID: 19765428
    [Abstract] [Full Text] [Related]

  • 12. HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients.
    Varga M, Rajczy K, Telkes G, Hídvégi M, Péter A, Remport A, Korbonits M, Fazakas J, Toronyi E, Sárváry E, Kóbori L, Járay J.
    Nephrol Dial Transplant; 2008 Aug; 23(8):2673-8. PubMed ID: 18332066
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. "Cytomegalovirus disease" in renal allograft recipients: is human herpesvirus 7 a co-factor for disease progression?
    Osman HK, Peiris JS, Taylor CE, Warwicker P, Jarrett RF, Madeley CR.
    J Med Virol; 1996 Apr; 48(4):295-301. PubMed ID: 8699160
    [Abstract] [Full Text] [Related]

  • 15. Long-term renal graft function and survival in patients with high-risk for cytomegalovirus infection receiving preemptive therapy.
    Alberú J, Morales-Buenrostro LE, Correa-Rotter R, Muñoz-Trejo T, Zúñiga-Varga J, Cuéllar-González JV, Mayorga-Madrigal H, Vanegas-Carrero R, Aranda F, Rodríguez-Romo R, Herrera-Garcia C, González-Michaca L, Sierra-Madero JG.
    Rev Invest Clin; 2008 Apr; 60(5):365-74. PubMed ID: 19227433
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients.
    Ahsan N, Holman MJ, Yang HC.
    Clin Transplant; 1997 Dec; 11(6):633-9. PubMed ID: 9408699
    [Abstract] [Full Text] [Related]

  • 17. Cytomegalovirus disease in kidney transplant recipients: incidence, clinical profile, and risk factors.
    Cordero E, Casasola C, Ecarma R, Danguilan R.
    Transplant Proc; 2012 Apr; 44(3):694-700. PubMed ID: 22483471
    [Abstract] [Full Text] [Related]

  • 18. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C.
    Burak KW, Kremers WK, Batts KP, Wiesner RH, Rosen CB, Razonable RR, Paya CV, Charlton MR.
    Liver Transpl; 2002 Apr; 8(4):362-9. PubMed ID: 11965581
    [Abstract] [Full Text] [Related]

  • 19. Overt cytomegalovirus (CMV) infection following renal transplantation--usefulness of CFA, NIA, PENA antibodies as markers in serological diagnosis and evaluation of risk factors influencing the manifestations of CMV infection.
    Nakamura K.
    Tokai J Exp Clin Med; 1982 Nov; 7(6):631-53. PubMed ID: 6306871
    [Abstract] [Full Text] [Related]

  • 20. Sero-molecular evaluation of human cytomegalovirus disease in renal transplant rejection.
    Kishore J, Mukhopadhyay C, Savitri, Ayyagari A, Sharma RK.
    Nepal Med Coll J; 2004 Dec; 6(2):83-7. PubMed ID: 16295735
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.